Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-016986
Filing Date
2024-06-14
Accepted
2024-06-14 17:38:40
Documents
1
Period of Report
2024-06-12

Document Format Files

Seq Description Document Type Size
1 form4-06142024_090636.html 4  
1 form4-06142024_090636.xml 4 5939
  Complete submission text file 0001415889-24-016986.txt   7364
Mailing Address C/O IDENIX PHARMACEUTICALS, INC. ONE KENDALL SQUARE, BLDG. 1400 CAMBRIDGE MA 02139
Business Address
Beckman Daniella (Reporting) CIK: 0001513422 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37359 | Film No.: 241046193

Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Issuer) CIK: 0001597264 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)